20.109(F11): Synthetic Lethality in Treating Medulloblastoma: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
Line 2: Line 2:


== References ==
== References ==
*Tanori, M., Mancuso, M., Pasquali1, E., Leonardi, S., Rebessi, S., Majo, V.D., Guilly, M.N., Giangaspero, F., Covelli, V., Pazzaglia, S., Saran, A. (2008). PARP-1 cooperates with Ptc1 to suppress medulloblastoma and basal cell carcinoma. Carcinogenesis, 29(10), 1911–1919. http://carcin.oxfordjournals.org/content/29/10/1911.full.pdf.
* Guo GS, Zhang FM, Gao RJ, Delsite R, Feng ZH, Powell SN. (2011) DNA repair and synthetic lethality. Int J Oral Sci. 3(4),176-179. http://www.ijos.org.cn/qikan/manage/wenzhang/85.pdf
 
* Tanori, M., Mancuso, M., Pasquali1, E., Leonardi, S., Rebessi, S., Majo, V.D., Guilly, M.N., Giangaspero, F., Covelli, V., Pazzaglia, S., Saran, A. (2008). PARP-1 cooperates with Ptc1 to suppress medulloblastoma and basal cell carcinoma. Carcinogenesis, 29(10), 1911–1919. http://carcin.oxfordjournals.org/content/29/10/1911.full.pdf


* Eberhart CG. (2003). Medulloblastoma in mice lacking p53 and PARP: all roads lead to Gli. Am J Pathol. 162(1), 7–10. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851103/
* Eberhart CG. (2003). Medulloblastoma in mice lacking p53 and PARP: all roads lead to Gli. Am J Pathol. 162(1), 7–10. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851103/

Revision as of 21:09, 29 November 2011

Synthetic Lethality in Treating Medulloblastoma

References

  • Tanori, M., Mancuso, M., Pasquali1, E., Leonardi, S., Rebessi, S., Majo, V.D., Guilly, M.N., Giangaspero, F., Covelli, V., Pazzaglia, S., Saran, A. (2008). PARP-1 cooperates with Ptc1 to suppress medulloblastoma and basal cell carcinoma. Carcinogenesis, 29(10), 1911–1919. http://carcin.oxfordjournals.org/content/29/10/1911.full.pdf